← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:963 | 963 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-517 | 70092-517-43 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:963 | 963 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-030 | 70092-030-36 | Midazolam Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:963 | 963 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-2 | Neostigmine Methylsulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:963 | 963 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:963 | 963 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5233 | 26436-5233-3 | Nystatin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:963 | 963 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:963 | 963 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-014 | 73198-014-05 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:964 | 964 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5137 | 26436-5137-5 | Trimix 20/30/2 | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:964 | 964 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-8 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:964 | 964 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1019 | 5446-1019-01 | Lidocaine; Hyaluronidase; Bupivacaine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:964 | 964 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lysine | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:964 | 964 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2431 | 72627-2431-1 | Magnesium Chloride Tetrahydrate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:964 | 964 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:964 | 964 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1480 | 5446-1480-01 | Lidocaine; Hyaluronidase; Racepinephrine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:964 | 964 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:964 | 964 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-097 | 71449-097-42 | Moxifloxacin Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:964 | 964 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1010 | 73013-1010-1 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:964 | 964 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:964 | 964 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-1 | Neostigmine Methylsulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:964 | 964 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:964 | 964 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5233 | 26436-5233-6 | Nystatin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:964 | 964 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:964 | 964 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-014 | 73198-014-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:965 | 965 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0203 | 72196-0203-1 | Modified St. Thomas Low K (62 mEq) High Sodium Bicarbonate 1000 mL Bag | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:965 | 965 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-7 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:965 | 965 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1548 | 5446-1548-01 | Lidocaine; Hyaluronidase; Bupivacaine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:965 | 965 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lysine | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:965 | 965 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Hydroxide; Aluminum Hydroxide; Dimethicone; Lidocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:965 | 965 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:965 | 965 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1256 | 5446-1256-01 | Lidocaine; Oxymetazoline Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:965 | 965 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6065 | 71286-6065-1 | Neostigmine Methylsulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:965 | 965 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:965 | 965 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:965 | 965 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:965 | 965 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1372 | 61141-1372-5 | Neostigmine Methylsulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:965 | 965 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:965 | 965 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ondansetron Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:965 | 965 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:965 | 965 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-013 | 73198-013-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:966 | 966 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-022 | 71506-022-35 | Ephedrine Sulfate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:966 | 966 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-4 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:966 | 966 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1177 | 5446-1177-01 | Lidocaine; Hyaluronidase; Bupivacaine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:966 | 966 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0401 | 72196-0401-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:966 | 966 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Sulfate Heptahydrate | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:966 | 966 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:966 | 966 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1118 | 5446-1118-01 | Lidocaine; Phenylephrine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:966 | 966 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-942 | 69374-942-04 | Neostigmine Methylsulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:966 | 966 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Bromfenac Sodium | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:966 | 966 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-04 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:966 | 966 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:966 | 966 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0329 | 60652-0329-1 | Neostigmine Methylsulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:966 | 966 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:966 | 966 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ondansetron Hydrochloride; Ketamine Hydrochloride; Midazolam | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:966 | 966 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:966 | 966 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-013 | 73198-013-05 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:967 | 967 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8310 | 71266-8310-1 | Tropicamide 1%, Phenylephrine 2.5% | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:967 | 967 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2000 | 71286-2000-1 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:967 | 967 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1480 | 5446-1480-01 | Lidocaine; Hyaluronidase; Racepinephrine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:967 | 967 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0401 | 71285-0401-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:967 | 967 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7080 | 71285-7080-1 | Magnesium Sulfate Heptahydrate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:967 | 967 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:967 | 967 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1045 | 5446-1045-03 | Lidocaine; Phenylephrine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:967 | 967 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:967 | 967 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:967 | 967 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-25 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:967 | 967 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-177 | 70092-177-35 | Midazolam Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:967 | 967 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:967 | 967 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:967 | 967 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-164 | 82396-164-13 | Oxycodone Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:967 | 967 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:967 | 967 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-013 | 73198-013-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:968 | 968 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4536 | 61141-4536-4 | Proparacaine HCl Repak 0.5%, 0.4ml in syringe | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:968 | 968 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2073 | 71286-2073-1 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:968 | 968 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0899 | 5446-0899-01 | Lidocaine; Hyaluronidase; Racepinephrine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:968 | 968 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0412 | 71285-0412-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:968 | 968 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-731 | 70004-731-30 | Magnesium Sulfate Heptahydrate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:968 | 968 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:968 | 968 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0790 | 5446-0790-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:968 | 968 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-139 | 63037-139-25 | Neostigmine Methylsulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:968 | 968 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Triamcinolone Acetonide | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:968 | 968 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-28 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:968 | 968 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:968 | 968 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:968 | 968 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:968 | 968 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-164 | 82396-164-25 | Oxycodone Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:968 | 968 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:968 | 968 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-024 | 73198-024-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:969 | 969 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-122 | 73198-122-30 | Sodium Tetradecyl Sulfate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:969 | 969 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-1 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:969 | 969 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1256 | 5446-1256-01 | Lidocaine; Oxymetazoline Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:969 | 969 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0415 | 71285-0415-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:969 | 969 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6147 | 71285-6147-1 | Magnesium Sulfate Heptahydrate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:969 | 969 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0217 | 72196-0217-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Calcium Chloride; Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Dextrose Monohydrate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:969 | 969 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0407 | 5446-0407-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:969 | 969 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1372 | 61141-1372-5 | Neostigmine Methylsulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:969 | 969 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0407 | 71285-0407-1 | N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:969 | 969 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-05 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:969 | 969 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-130 | 71449-130-32 | Midazolam Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:969 | 969 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:969 | 969 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:969 | 969 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6044 | 71285-6044-1 | Oxytocin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:969 | 969 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:969 | 969 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-024 | 73198-024-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:970 | 970 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-104 | 70092-104-36 | Fent 2 mcg/ml-Bup 0.125% PF 100ml NS IVB | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:970 | 970 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-2 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:970 | 970 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1118 | 5446-1118-01 | Lidocaine; Phenylephrine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:970 | 970 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0415 | 72196-0415-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:970 | 970 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6148 | 71285-6148-1 | Magnesium Sulfate Heptahydrate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:970 | 970 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0211 | 72196-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:970 | 970 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1018 | 5446-1018-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:970 | 970 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0329 | 60652-0329-1 | Neostigmine Methylsulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:970 | 970 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0408 | 72196-0408-1 | N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Lysine Acetate; Serine; Glutamic Acid; Tyrosine | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:970 | 970 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-30 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:970 | 970 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-418 | 70092-418-36 | Midazolam Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:970 | 970 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5066 | 26436-5066-3 | Niacinamide | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:970 | 970 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5020 | 71266-5020-2 | Norepinephrine Bitartrate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:970 | 970 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8069 | 71285-8069-1 | Oxytocin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:970 | 970 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:970 | 970 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-024 | 73198-024-05 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:971 | 971 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-259 | 70092-259-75 | Fent 2mcg/mL-Rop 0.2% PF 100ml NS CADDYFS | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:971 | 971 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2001 | 71286-2001-1 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:971 | 971 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1045 | 5446-1045-03 | Lidocaine; Phenylephrine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:971 | 971 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0425 | 71285-0425-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:971 | 971 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6048 | 71285-6048-1 | Magnesium Sulfate Heptahydrate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:971 | 971 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0211 | 71285-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:971 | 971 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0408 | 5446-0408-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:971 | 971 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-932 | 69374-932-33 | Neostigmine Methylsulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:971 | 971 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-141 | 73702-141-32 | Naloxone Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:971 | 971 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-01 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:971 | 971 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-029 | 70092-029-35 | Midazolam Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:971 | 971 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2414 | 72934-2414-2 | Niacinamide; Azelaic Acid | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:971 | 971 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5025 | 71266-5025-2 | Norepinephrine Bitartrate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:971 | 971 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5000 | 71266-5000-1 | Oxytocin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:971 | 971 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:971 | 971 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-005 | 73198-005-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:972 | 972 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2402 | 72627-2402-1 | Glutathione | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:972 | 972 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2001 | 71286-2001-2 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:972 | 972 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0790 | 5446-0790-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:972 | 972 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0430 | 71285-0430-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:972 | 972 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6147 | 72196-6147-1 | Magnesium Sulfate Heptahydrate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:972 | 972 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Benzocaine | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:972 | 972 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1552 | 73271-1552-1 | Lidocaine; Prilocaine; Tetracaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:972 | 972 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-932 | 69374-932-03 | Neostigmine Methylsulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:972 | 972 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2107 | 72627-2107-3 | Nandrolone Decanoate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:972 | 972 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-16 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:972 | 972 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4356 | 72934-4356-8 | Minoxidil; Niacinamide | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:972 | 972 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2395 | 72934-2395-2 | Niacinamide; Calcipotriene | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:972 | 972 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5015 | 71266-5015-2 | Norepinephrine Bitartrate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:972 | 972 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5100 | 71266-5100-1 | Oxytocin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:972 | 972 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:972 | 972 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-005 | 73198-005-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:973 | 973 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-161 | 70092-161-43 | Methadone PF 1mg/ml in 1ml NS- 3ml syr | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:973 | 973 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-013 | 71449-013-32 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:973 | 973 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0407 | 5446-0407-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:973 | 973 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0422 | 71285-0422-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:973 | 973 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6148 | 72196-6148-1 | Magnesium Sulfate Heptahydrate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:973 | 973 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:973 | 973 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-7114 | 73271-7114-1 | Lidocaine; Prilocaine; Tetracaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:973 | 973 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-902 | 69374-902-05 | Neostigmine Methylsulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:973 | 973 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6220 | 72682-6220-1 | Nandrolone Decanoate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:973 | 973 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-6795 | 60652-6795-2 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:973 | 973 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4355 | 72934-4355-8 | Minoxidil; Progesterone | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:973 | 973 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-3303 | 72934-3303-3 | Niacinamide; Clindamycin Phosphate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:973 | 973 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5233 | 26436-5233-6 | Nystatin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:973 | 973 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-028 | 71506-028-59 | Oxytocin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:973 | 973 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:973 | 973 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-005 | 73198-005-05 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:974 | 974 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0018 | 71139-0018-1 | Hydromorphone HYDROCHLORIDE CADD | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:974 | 974 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:974 | 974 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1018 | 5446-1018-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:974 | 974 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0422 | 72196-0422-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:974 | 974 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6048 | 72196-6048-1 | Magnesium Sulfate Heptahydrate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:974 | 974 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:974 | 974 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-4114 | 73271-4114-1 | Lidocaine; Prilocaine; Tetracaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:974 | 974 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6065 | 72196-6065-1 | Neostigmine Methylsulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:974 | 974 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:974 | 974 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-02 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:974 | 974 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8515 | 71266-8515-3 | Mitomycin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:974 | 974 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2364 | 72934-2364-3 | Niacinamide; Clobetasol Propionate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:974 | 974 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5233 | 26436-5233-3 | Nystatin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:974 | 974 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6042 | 71285-6042-1 | Oxytocin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:974 | 974 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:974 | 974 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-023 | 73198-023-05 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:975 | 975 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2412 | 72627-2412-1 | Dexpanthenol | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:975 | 975 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:975 | 975 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0408 | 5446-0408-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:975 | 975 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0416 | 72196-0416-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:975 | 975 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8073 | 71285-8073-1 | Magnesium Sulfate Heptahydrate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:975 | 975 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Prilocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:975 | 975 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-2552 | 73271-2552-1 | Lidocaine; Prilocaine; Tetracaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:975 | 975 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-125 | 71449-125-11 | Neostigmine Methylsulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:975 | 975 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-126 | 73177-126-02 | Neostigmine | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:975 | 975 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2041 | 71286-2041-2 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:975 | 975 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8475 | 71266-8475-3 | Mitomycin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:975 | 975 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2321 | 72934-2321-2 | Niacinamide; Dapsone | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:975 | 975 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ondansetron Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:975 | 975 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6044 | 72196-6044-1 | Oxytocin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:975 | 975 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5580 | 26436-5580-1 | Phenol | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:975 | 975 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-023 | 73198-023-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:976 | 976 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7023 | 72196-7023-1 | Heparin 5000units added to NS | 2025-2 | valid | 0 | 2026-09-18 |